Note: Ingredients listed on restricted chemical lists
EC/CAS
71751-41-2
Name of the chemical
Abamectin (Kombination von Abamectin B1a und Abamectin B1b) (ISO); Abamectin B1a (Reinheit ≥ 80 %) (618/2012)
Concentration
N/A
General Information
Revision date
2008-05-28
Product name
AVOMEC Plus Pour-On Roundworm, Liver Fluke and External Parasiticide
Substance name
Abamectin is a macrocyclic lactone; triclabendazole is a benzimidazole
1.2.1 Relevant identified uses
Pour-on treatment for certain internal and external parasites on cattle as
supplier name
Merial Australia
Icons in SDS
Company Information
company name
Merial Australia
Section 2
SECTION 2: Hazards identification
This product is classified as: Hazardous according to the criteria of NOHSC Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code.
Hazard statements
R22, R52, R36/38 HARMFUL IF SWALLOWED. HARMFUL TO AQUATIC ORGANISMS. IRRITATING TO EYES AND SKIN.
Precautionary statements
S20, S44, S61, S24/25. WHEN USING, DO NOT EAT OR DRINK. IF YOU FEEL UNWELL, CONTACT A DOCTOR OR POISONS INFORMATION CENTRE IMMEDIATELY (SHOW THE LABEL WHERE POSSIBLE). AVOID RELEASE TO THE ENVIRONMENT. REFER TO SPECIAL INSTRUCTIONS/SAFETY DATA SHEETS. AVOID CONTACT WITH SKIN AND EYES.
SUSDP Classification
S6 ADG CODE CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code
UN Number
None allocated. EMERGENCY OVERVIEW: PHYSICAL DESCRIPTION & COLOUR: Clear brown liquid. ODOUR: No data
Health hazards
Symptoms of Abamectin poisoning observed in laboratory animals include pupil dilation, vomiting, convulsions and/or tremors, and coma. At very high doses, it can affect mammals, causing symptoms of nervous system depression such as incoordination, tremors, lethargy, excitation, and pupil dilation. Very high doses have caused death from respiratory failure. Irritating to eyes and skin, harmful if swallowed. Triclabendazole is NOT harmful: LD50 Rat>8000 mg/kg Oral (mouse) LD50: >8000 mg/kg Inhalation (rat) LC50: >500 mg/m3/4h Dermal (rat) LD50: >4000 mg/kg
Potential health effects
See section 11 for Chronic exposure studies. Inhalation Short Term Exposure: Significant inhalation exposure is considered to be unlikely. Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. Skin Contact: Short Term Exposure: Available data indicates that this product is not harmful. It should present no hazards in normal use. However product is a skin irritant. Symptoms may include itchiness and reddening of contacted skin. Other symptoms may also become evident, but all should disappear once exposure has ceased. Eye Contact: Short Term Exposure: Exposure via eyes is considered to be unlikely. This product is an eye irritant. Symptoms may include stinging and reddening of eyes and watering which may become copious. Other symptoms may also become evident. If exposure is brief, symptoms should disappear once exposure has ceased. However, lengthy exposure or delayed treatment may cause permanent damage. Ingestion: Short Term Exposure: Significant oral exposure is considered to be unlikely. Available data shows that this product is harmful, and is likely to cause headache and gastric disturbance such as nausea and vomiting if ingested in significant quantities. This product is unlikely to cause any irritation problems in the long term. Carcinogen Status: NOHSC: No significant ingredient is classified as carcinogenic by NOHSC. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: No significant ingredient is classified as carcinogenic by IARC.
